1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY SERVICE TYPE
5.1. Introduction
5.2. Manufacturing
5.3. Packaging & Labeling
5.4. Storing
5.5. Others
6. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY CLINICAL PHASE
6.1. Introduction
6.2. Phase 1
6.3. Phase 2
6.4. Phase 3
6.5. Phase 4
7. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY APPLICATION
7.1. Introduction
7.2. Oncology
7.3. Cardiology
7.4. Respiratory Disease
7.5. CNS & Mental Disorders
7.6. Others
8. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY END-USER
8.1. Introduction
8.2. Pharmaceutical & Biotechnology Companies
8.3. Contract Research Organization (CRO)
8.4. Others
9. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Italy
9.4.5. Spain
9.4.6. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Israel
9.5.4. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Taiwan
9.6.8. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. DHL International GmbH
11.2. Marken
11.3. Parexel International Corporation
11.4. Movianto
11.5. Catalent Inc.
11.6. Thermo Fisher Scientific Inc.
11.7. Almac Group
11.8. FedEx
11.9. PCI Pharma Service
11.10. Sharp Services, LLC
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES